Colchicine poisoning complicated by medulla oblongata myelinolysis: a case report

Ann Palliat Med. 2021 Feb;10(2):2349-2353. doi: 10.21037/apm-19-627. Epub 2020 May 25.

Abstract

Medulla oblongata myelinolysis is an extremely rare manifestation of extrapontine myelinolysis (EPM). Herein, we report a case of a 34-year-old man with a history of gout who presented repeated vomiting and diarrhea after ingesting 15 colchicine pills. A hyponatremia diagnosis was given and after an intensive treatment, his serum sodium level increased from 118 to 129 mmol/L within 24 hours. Brain magnetic resonance imaging (MRI) revealed a lesion in the medulla oblongata that appeared as a hypointense area in T1-weighted images and a hyperintense area in T2-weighted images. A diagnosis of medulla oblongata myelinolysis and colchicine poisoning was then given, and methylprednisolone therapy was initiated. Seventeen days later, the patient achieved a good outcome with methylprednisolone therapy. However, his medulla oblongata lesion remained detectable with MRI. Medulla oblongata myelinolysis is an extremely rare manifestation of EPM, and unique for being colchicine-induced. This case shows that colchicine poisoning can lead to hyponatremia, which in turn can induce myelinolysis if not treated correctly. As exemplified by our patient's case, desirable treatment outcomes are possible in such cases, although these outcomes may not be associated with a visible reduction of the brain lesions in MRI scans.

Keywords: Colchicine; case report; demyelinating diseases; medulla oblongata; myelin sheath.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Colchicine
  • Humans
  • Hyponatremia*
  • Magnetic Resonance Imaging
  • Male
  • Medulla Oblongata / diagnostic imaging
  • Myelinolysis, Central Pontine* / chemically induced
  • Myelinolysis, Central Pontine* / diagnostic imaging

Substances

  • Colchicine